BlackRock Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

BlackRock Group’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.03M	Buy	45,968 +2,329	+5%	+$45.5K	﹤0.01%	2114
2016 Q3	$991K	Buy	43,639 +997	+2%	+$23.4K	﹤0.01%	2042
2016 Q2	$1.01M	Sell	42,642 -10,993	-20%	-$271K	﹤0.01%	1968
2016 Q1	$1.09M	Buy	53,635 +26,488	+98%	+$840K	﹤0.01%	1896
2015 Q4	$1.4M	Buy	27,147 +6,184	+29%	+$300K	﹤0.01%	1685
2015 Q3	$894K	Buy	20,963 +10,416	+99%	+$503K	﹤0.01%	1948
2015 Q2	$481K	Buy	10,547 +1,596	+18%	+$64.2K	﹤0.01%	2283
2015 Q1	$340K	Buy	8,951 +4,497	+101%	+$154K	﹤0.01%	2323
2014 Q4	$126K	Buy	+4,454	New	+$124K	﹤0.01%	2623
2013 Q4	–	Sell	-3,280	Closed	-$88K	–	2824
2013 Q3	$88K	Buy	+3,280	New	+$78.1K	﹤0.01%	2629

Other funds holding PTLA

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock Group's PTLA Position: Q4 2016 in Review

BlackRock Group increased its Portola Pharmaceuticals, Inc. (PTLA) stake by 5.3% in Q4 2016, buying an estimated $45.5K and bringing the position to 45,968 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2114.

BlackRock Group first reported a position in PTLA in Q3 2013 and has held it in 10 quarters since. The position peaked at $1.4M in Q4 2015. 150 funds tracked by Wall St. Rank hold PTLA as of Q4 2016.

BlackRock Group held 45,968 shares of Portola Pharmaceuticals, Inc. worth $1.03M as of Q4 2016.
BlackRock Group bought 2,329 Portola Pharmaceuticals, Inc. shares in Q4 2016, an estimated $45.5K.
Portola Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2114 holding.
BlackRock Group first reported a position in Portola Pharmaceuticals, Inc. in Q3 2013 and has held it in 10 quarters since.
BlackRock Group's Portola Pharmaceuticals, Inc. position peaked at $1.4M in Q4 2015.
150 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.